GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (XCNQ:XTRX) » Definitions » Sloan Ratio %

Adastra Holdings (XCNQ:XTRX) Sloan Ratio % : -14.08% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Adastra Holdings Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Adastra Holdings's Sloan Ratio for the quarter that ended in Mar. 2024 was -14.08%.

As of Mar. 2024, Adastra Holdings has a Sloan Ratio of -14.08%, indicating there is a warning stage of accrual build up.


Adastra Holdings Sloan Ratio % Historical Data

The historical data trend for Adastra Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adastra Holdings Sloan Ratio % Chart

Adastra Holdings Annual Data
Trend Apr19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
- -21.76 -4.98 -14.38 -14.61

Adastra Holdings Quarterly Data
Oct18 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.38 -19.80 -20.59 -14.51 -14.08

Competitive Comparison of Adastra Holdings's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, Adastra Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adastra Holdings's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adastra Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Adastra Holdings's Sloan Ratio % falls into.



Adastra Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Adastra Holdings's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-3.545-1.861
--0.681)/32.343
=-14.61%

Adastra Holdings's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(-4.513-0.311
--0.489)/30.791
=-14.08%

Adastra Holdings's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was -1.071 (Jun. 2023 ) + -0.642 (Sep. 2023 ) + -1.49 (Dec. 2023 ) + -1.31 (Mar. 2024 ) = C$-4.51 Mil.
Adastra Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 0.376 (Jun. 2023 ) + 0.36 (Sep. 2023 ) + -0.374 (Dec. 2023 ) + -0.051 (Mar. 2024 ) = C$0.31 Mil.
Adastra Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -0.177 (Jun. 2023 ) + -0.108 (Sep. 2023 ) + 0.081 (Dec. 2023 ) + -0.285 (Mar. 2024 ) = C$-0.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adastra Holdings  (XCNQ:XTRX) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Adastra Holdings has a Sloan Ratio of -14.08%, indicating there is a warning stage of accrual build up.


Adastra Holdings Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Adastra Holdings's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Adastra Holdings (XCNQ:XTRX) Business Description

Traded in Other Exchanges
Address
275th Street, Suite 5451, Langley, BC, CAN, V4W 3X8
Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.
Executives
Lachlan Clyde Mcleod Senior Officer

Adastra Holdings (XCNQ:XTRX) Headlines

No Headlines